Canopy Growth (CGC) Gross Profit (QoQ) (2019 - 2025)
Canopy Growth (CGC) Gross Profit (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - |
| 7 | Viatris | 20.23 Bn | 18.42 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Canopy Growth | 277.27 Mn | 11.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 176.66% |
| Sep 30, 2025 | 22.27% |
| Dec 31, 2024 | 7.76% |
| Sep 30, 2024 | -4.93% |
| Jun 30, 2024 | 46.69% |
| Mar 31, 2024 | -44.63% |
| Dec 31, 2023 | 18.65% |
| Sep 30, 2023 | 70.56% |
| Jun 30, 2023 | 121.53% |
| Mar 31, 2023 | -1,335.32% |
| Dec 31, 2022 | 922.12% |
| Sep 30, 2022 | 89.31% |
| Jun 30, 2022 | 96.39% |
| Mar 31, 2022 | -1,614.91% |
| Dec 31, 2021 | 114.16% |
| Sep 30, 2021 | -355.04% |
| Jun 30, 2021 | 186.18% |
| Mar 31, 2021 | -58.94% |
| Dec 31, 2020 | -3.64% |
| Sep 30, 2020 | 317.81% |